Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma

被引:21
|
作者
Hwang, Chungsu [1 ,2 ]
Lee, So Jung [3 ]
Lee, Jung Hee [1 ,2 ]
Kim, Ki Hyung [4 ]
Suh, Dong Soo [4 ]
Kwon, Byung-Su [4 ]
Choi, Kyung Un [3 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Dept Pathol, Yangsan 50612, Gyeongsangnam D, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 50612, Gyeongsangnam D, South Korea
[3] Pusan Natl Univ Hosp, Dept Pathol, Busan 602739, South Korea
[4] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Busan 602739, South Korea
关键词
ovarian cancer; tumor-infiltrating lymphocyte; survival; hematoxylin; eosin; BREAST-CANCER; T-CELLS; CHEMOTHERAPY; SURVIVAL; TILS;
D O I
10.3892/ol.2019.10095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on tumor-infiltrating lymphocytes (TILs) in epithelial ovarian cancer (EOC) have focused on the clinical significance of inflammatory cells of specific subtypes that are identifiable using immunohistochemistry. However, the subtypes of inflammatory cells that reportedly affect patient survival and prognosis have differed from study to study, and few studies have examined TILs using hematoxylin and eosin (H&E) staining. Therefore, the present study aimed to identify the clinical importance of general stromal TILs in EOC by using H&E staining to apply breast cancer recommendations from the International TILs Working Group 2014 on breast cancer using H&E staining. Stromal TILs in 256 EOC cases from Pusan National University Hospital and 475 cases of high-grade serous carcinoma from The Cancer Genome Atlas dataset were assessed. Stromal TILs were evaluated using H&E-stained slides according to the breast cancer recommendations of the International Working Group 2014, and patients were classified into low and high stromal TIL groups according to their stromal TIL values. The associations of these groups with clinicopathologic factors were assessed, and it was confirmed that group membership correlated with survival and prognosis. According to the (2) assessment, the stromal TIL group was associated with tumor grade. Furthermore, the stromal TIL group was associated with overall survival according to Kaplan-Meier analysis with the log-rank test. Finally, the stromal TIL group was an independent prognostic factor according to univariate and multivariate Cox regression analyses. In cases of EOC, the evaluation of general stromal TILs on H&E-stained slides could be used to predict prognosis.
引用
收藏
页码:4557 / 4565
页数:9
相关论文
共 44 条
  • [31] Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
    Darb-Esfahani, Silvia
    Kunze, Catarina Alisa
    Kulbe, Hagen
    Sehouli, Jalid
    Wienert, Stephan
    Lindner, Judith
    Budczies, Jan
    Bockmayr, Michael
    Dietel, Manfred
    Denkert, Carsten
    Braicu, Ioana
    Joehrens, Korinna
    ONCOTARGET, 2016, 7 (02) : 1486 - 1499
  • [32] Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - A study of the OVCAD consortium
    Pils, Dietmar
    Bachmayr-Heyda, Anna
    Auer, Katharina
    Svoboda, Martin
    Auner, Veronika
    Hager, Gudrun
    Obermayr, Eva
    Reiner, Angelika
    Reinthaller, Alexander
    Speiser, Paul
    Braicu, Ioana
    Sehouli, Jalid
    Lambrechts, Sandrina
    Vergote, Ignace
    Mahner, Sven
    Berger, Astrid
    Castillo-Tong, Dan Cacsire
    Zeillinger, Robert
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 99 - 110
  • [33] Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
    Strickland, Kyle C.
    Howitt, Brooke E.
    Shukla, Sachet A.
    Rodig, Scott
    Ritterhouse, Lauren L.
    Liu, Joyce F.
    Garber, Judy E.
    Chowdhury, Dipanjan
    Wu, Catherine J.
    D'Andrea, Alan D.
    Matulonis, Ursula A.
    Konstantinopoulos, Panagiotis A.
    ONCOTARGET, 2016, 7 (12) : 13587 - 13598
  • [34] Computer extracted features related to the spatial arrangement of tumor-infiltrating lymphocytes predict overall survival in epithelial ovarian cancer receiving adjuvant chemotherapy
    Azarianpour, Sepideh
    Corredor, German
    Bera, Kaustav
    Leo, Patrick
    Braman, Nathaniel
    Fu, Pingfu
    Mahdi, Haider
    Madabhushi, Anant
    MEDICAL IMAGING 2020: DIGITAL PATHOLOGY, 2021, 11320
  • [35] Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer
    Wang, Qiaohong
    Lou, Weihua
    Di, Wen
    Wu, Xia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 7 - 14
  • [36] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    de la Fuente, Laura Martin
    Westbom-Fremer, Sofia
    Arildsen, Nicolai Skovbjerg
    Hartman, Linda
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Hedenfalk, Ingrid
    VIRCHOWS ARCHIV, 2020, 477 (01) : 83 - 91
  • [37] Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
    Rakaee, Mehrdad
    Kilvaer, Thomas K.
    Dalen, Stig Manfred
    Richardsen, Elin
    Paulsen, Erna-Elise
    Hald, Sigurd M.
    Al-Saad, Samer
    Andersen, Sigve
    Donnem, Tom
    Bremnes, Roy M.
    Busund, Lill-Tove
    HUMAN PATHOLOGY, 2018, 79 : 188 - 198
  • [38] The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
    P M O'Brien
    M J Davies
    J P Scurry
    A N Smith
    C A Barton
    M J Henderson
    D N Saunders
    B S Gloss
    K I Patterson
    J L Clancy
    V A Heinzelmann-Schwarz
    R A Scolyer
    Y Zeng
    E D Williams
    L Scurr
    A DeFazio
    D I Quinn
    C K W Watts
    N F Hacker
    S M Henshall
    R L Sutherland
    British Journal of Cancer, 2008, 98 : 1085 - 1093
  • [39] The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
    O'Brien, P. M.
    Davies, M. J.
    Scurry, J. P.
    Smith, A. N.
    Barton, C. A.
    Henderson, M. J.
    Saunders, D. N.
    Gloss, B. S.
    Patterson, K. I.
    Clancy, J. L.
    Heinzelmann-Schwarz, V. A.
    Scolyer, R. A.
    Zeng, Y.
    Williams, E. D.
    Scurr, L.
    DeFazio, A.
    Quinn, D. I.
    Watts, C. K. W.
    Hacker, N. F.
    Henshall, S. M.
    Sutherland, R. L.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1085 - 1093
  • [40] SOLID-PHASE ANTI-CD3 ANTIBODY ACTIVATION AND CRYOPRESERVATION OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM EPITHELIAL OVARIAN-CANCER
    IKARASHI, H
    AOKI, Y
    FUJITA, K
    KODAMA, S
    TANAKA, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (12): : 1359 - 1365